25 May 2013
Keywords: preclinical, program, rhudex, nearing, completion, uk-based, avidex
Article | 10 January 2005
UK-based Avidex says that its preclinical program evaluating RhuDex as a therapy for rheumatoid arthritis is drawing to a close ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
24 May 2013
© 2013 thepharmaletter.com